<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03273426</url>
  </required_header>
  <id_info>
    <org_study_id>SNUHBCC002</org_study_id>
    <nct_id>NCT03273426</nct_id>
  </id_info>
  <brief_title>Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.</brief_title>
  <official_title>Prediction of Pathologic Complete Response by Multiple Core Needle Biopsy or Vacuum Assisted Biopsy Before Surgery in Breast Cancer With Complete Clinical Response After Neoadjuvant Chemotherapy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the ability of preoperative biopsy to predict
      correctly pathologic complete response in breast cancer patients with complete clinical
      response after neoadjuvant chemotherapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Breast cancer patients who received neoadjuvant chemotherapy and is predicted to have
      achieved pathologic complete response (pCR) on MRI will enrolled. The enrolled patients will
      undergo either US-guided multiple core needle biopsy or US-guided vacuum-assisted biopsy of
      the tumor bed where it had been marked with an indicator (clip). The patient will undergo
      subsequent wide excision of the tumor bed. Histopathologic findings of the biopsy and the
      surgical specimen will be compared for pCR, and the ability of preoperative biopsies to
      predict pCR will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 8, 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Negative predictive value</measure>
    <time_frame>2 weeks</time_frame>
    <description>Rate of pathologic complete response (pCR) confirmed by surgical excision in patients predicted by biopsy to have pCR.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>false negative rate</measure>
    <time_frame>2 weeks</time_frame>
    <description>Rate of residual tumor in patients predicted by biopsy to have pCR.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Breast Neoplasm</condition>
  <arm_group>
    <arm_group_label>complete clinical response</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention (core needle biopsy or vacuum-assisted biopsy) for complete clinical response (cCR) or near-cCR predicted by MRI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>core needle biopsy</intervention_name>
    <description>Ultrasound-guided core needle biopsy (14G x ≥5) for complete clinical response (cCR) or near-cCR predicted by MRI.</description>
    <arm_group_label>complete clinical response</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>vacuum-assisted biopsy</intervention_name>
    <description>Ultrasound-guided vacuum-assisted biopsy (10G x ≥5) for complete clinical response (cCR) or near-cCR predicted by MRI.</description>
    <arm_group_label>complete clinical response</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients

          -  with unilateral primary cancer pathologically confirmed before neoadjuvant
             chemotherapy (NAC)

          -  who received NAC

          -  with detectable lesion / clip marker on ultrasound

          -  with cT1-T3 tumors

          -  clinical and imaging complete or near-complete response on MRI

          -  with informed consent

        Exclusion Criteria:

          -  Multifocal cancer

          -  Residual microcalcification

          -  Contralateral breast cancer
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wonshik Han, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wonshik Han, MD, PhD</last_name>
    <phone>+82-2-2072-1958</phone>
    <email>hanw@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Han-Byoel Lee, MD</last_name>
    <phone>+82-2-2072-2817</phone>
    <email>hblee80@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wonshik Han, MD</last_name>
      <phone>02-2072-1958</phone>
      <email>hanw@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2017</study_first_submitted>
  <study_first_submitted_qc>September 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 6, 2017</study_first_posted>
  <last_update_submitted>September 4, 2017</last_update_submitted>
  <last_update_submitted_qc>September 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Wonshik Han</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>IPD including study protocol, informed consent form, clinical study report and analytic code will be shared.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

